148 related articles for article (PubMed ID: 2024960)
1. Inhibition of Plasmodium falciparum dihydropteroate synthetase and growth in vitro by sulfa drugs.
Zhang Y; Meshnick SR
Antimicrob Agents Chemother; 1991 Feb; 35(2):267-71. PubMed ID: 2024960
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of recombinant Pneumocystis carinii dihydropteroate synthetase by sulfa drugs.
Hong YL; Hossler PA; Calhoun DH; Meshnick SR
Antimicrob Agents Chemother; 1995 Aug; 39(8):1756-63. PubMed ID: 7486915
[TBL] [Abstract][Full Text] [Related]
3. Sulfa drugs strike more than once.
Patel OG; Mberu EK; Nzila AM; Macreadie IG
Trends Parasitol; 2004 Jan; 20(1):1-3. PubMed ID: 14700578
[No Abstract] [Full Text] [Related]
4. Interaction of Pneumocystis carinii dihydropteroate synthase with sulfonamides and diaminodiphenyl sulfone (dapsone).
Voeller D; Kovacs J; Andrawis V; Chu E; Masur H; Allegra C
J Infect Dis; 1994 Feb; 169(2):456-9. PubMed ID: 8106784
[TBL] [Abstract][Full Text] [Related]
5. Sulfa-drug resistance in Plasmodium falciparum.
Hyde JE; Sims PF
Trends Parasitol; 2001 Jun; 17(6):265-6. PubMed ID: 11426433
[No Abstract] [Full Text] [Related]
6. Analysis in Escherichia coli of Plasmodium falciparum dihydropteroate synthase (DHPS) alleles implicated in resistance to sulfadoxine.
Berglez J; Iliades P; Sirawaraporn W; Coloe P; Macreadie I
Int J Parasitol; 2004 Jan; 34(1):95-100. PubMed ID: 14711594
[TBL] [Abstract][Full Text] [Related]
7. The structure of Plasmodium falciparum hydroxymethyldihydropterin pyrophosphokinase-dihydropteroate synthase reveals the basis of sulfa resistance.
Chitnumsub P; Jaruwat A; Talawanich Y; Noytanom K; Liwnaree B; Poen S; Yuthavong Y
FEBS J; 2020 Aug; 287(15):3273-3297. PubMed ID: 31883412
[TBL] [Abstract][Full Text] [Related]
8. Binding Isotope Effects for para-Aminobenzoic Acid with Dihydropteroate Synthase from Staphylococcus aureus and Plasmodium falciparum.
Stratton CF; Namanja-Magliano HA; Cameron SA; Schramm VL
ACS Chem Biol; 2015 Oct; 10(10):2182-6. PubMed ID: 26288086
[TBL] [Abstract][Full Text] [Related]
9. Use of bacterial surrogates as a tool to explore antimalarial drug interaction: Synergism between inhibitors of malarial dihydrofolate reductase and dihydropteroate synthase.
Talawanich Y; Kamchonwongpaisan S; Sirawaraporn W; Yuthavong Y
Acta Trop; 2015 Sep; 149():64-9. PubMed ID: 25997881
[TBL] [Abstract][Full Text] [Related]
10. Plasmodium falciparum: in vitro activity of sulfadoxine and dapsone in field isolates from Kenya: point mutations in dihydropteroate synthase may not be the only determinants in sulfa resistance.
Mberu EK; Nzila AM; Nduati E; Ross A; Monks SM; Kokwaro GO; Watkins WM; Hopkins Sibley C
Exp Parasitol; 2002; 101(2-3):90-6. PubMed ID: 12427462
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Pneumocystis carinii dihydropteroate synthetase by sulfa drugs.
Merali S; Zhang Y; Sloan D; Meshnick S
Antimicrob Agents Chemother; 1990 Jun; 34(6):1075-8. PubMed ID: 2203302
[TBL] [Abstract][Full Text] [Related]
12. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum.
Triglia T; Menting JG; Wilson C; Cowman AF
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13944-9. PubMed ID: 9391132
[TBL] [Abstract][Full Text] [Related]
13. Toxoplasma gondii: characterization of a mutant resistant to sulfonamides.
Pfefferkorn ER; Borotz SE; Nothnagel RF
Exp Parasitol; 1992 May; 74(3):261-70. PubMed ID: 1582478
[TBL] [Abstract][Full Text] [Related]
14. In vitro activities of novel antifolate drug combinations against Plasmodium falciparum and human granulocyte CFUs.
Winstanley PA; Mberu EK; Szwandt IS; Breckenridge AM; Watkins WM
Antimicrob Agents Chemother; 1995 Apr; 39(4):948-52. PubMed ID: 7786001
[TBL] [Abstract][Full Text] [Related]
15. Arabidopsis dihydropteroate synthase: general properties and inhibition by reaction product and sulfonamides.
Prabhu V; Lui H; King J
Phytochemistry; 1997 May; 45(1):23-7. PubMed ID: 9127492
[TBL] [Abstract][Full Text] [Related]
16. Associations of antifolate resistance in vitro and point mutations in dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum.
Biswas S
J Postgrad Med; 2004; 50(1):17-20. PubMed ID: 15047993
[TBL] [Abstract][Full Text] [Related]
17. Folate metabolism in malaria.
Ferone R
Bull World Health Organ; 1977; 55(2-3):291-8. PubMed ID: 338184
[TBL] [Abstract][Full Text] [Related]
18. Interaction of sulfonamide and sulfone compounds with Toxoplasma gondii dihydropteroate synthase.
Allegra CJ; Boarman D; Kovacs JA; Morrison P; Beaver J; Chabner BA; Masur H
J Clin Invest; 1990 Feb; 85(2):371-9. PubMed ID: 2298911
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of 2,4-diaminoquinazoline and 2,4-diaminopteridine derivatives against Plasmodium falciparum.
Ommeh S; Nduati E; Mberu E; Kokwaro G; Marsh K; Rosowsky A; Nzila A
Antimicrob Agents Chemother; 2004 Oct; 48(10):3711-4. PubMed ID: 15388424
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the Pneumocystis jirovecii DHPS gene confer cross-resistance to sulfa drugs.
Iliades P; Meshnick SR; Macreadie IG
Antimicrob Agents Chemother; 2005 Feb; 49(2):741-8. PubMed ID: 15673759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
